Investigadores
Inicio
Investigadores
Universidad de Santiago de Compostela (USC).
Desarrollos Tecnológicos y Terapéuticos
José Luis Labandeira García
Investigador principal
Grupo de Investigación: Universidad de Santiago de Compostela (USC).
Ana Isabel Rodríguez Pérez
Investigador colaborador
Grupo de Investigación: Universidad de Santiago de Compostela (USC).
Ana Mª Muñoz Patiño
Investigador colaborador
Grupo de Investigación: Universidad de Santiago de Compostela (USC).
Begoña Villar Cheda
Investigador colaborador
Grupo de Investigación: Universidad de Santiago de Compostela (USC).
Jannette Rodríguez Pallares
Investigador colaborador
Grupo de Investigación: Universidad de Santiago de Compostela (USC).
Juan Andrés Parga Martín
Investigador colaborador
Grupo de Investigación: Universidad de Santiago de Compostela (USC).
Juan Antonio Suárez Quintanilla
Investigador colaborador
Grupo de Investigación: Universidad de Santiago de Compostela (USC).
María del Carmen Díaz Ruiz
Investigador colaborador
Grupo de Investigación: Universidad de Santiago de Compostela (USC).
PABLO GARRIDO GIL
Investigador colaborador
Grupo de Investigación: Universidad de Santiago de Compostela (USC).
Rita Valenzuela Limiñana
Investigador colaborador
Grupo de Investigación: Universidad de Santiago de Compostela (USC).
Lage L., Rodriguez-Perez A.I., Labandeira-Garcia J.L., Dominguez-Meijide A.. Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms. Neurotherapeutics. 2025. DOI: 10.1016/j.neurot.2025.e00544.
Impacto: 5.6. Cuartil: Q1
Rodríguez-Pérez A.I., Garrido-Gil P., García-Garrote M., Muñoz A., Parga J.A., Labandeira-García J.L., Rodríguez-Pallares J.. Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models. Stem Cell Research and Therapy. December 2024. DOI: 10.1186/s13287-024-03751-y.
Impacto: 7.1. Cuartil: Q1
(1er decil)
Labandeira-Garcia J.L., Labandeira C.M., Guerra M.J., Rodriguez-Perez A.I.. The role of the brain renin-angiotensin system in Parkinson´s disease. Translational Neurodegeneration. December 2024. DOI: 10.1186/s40035-024-00410-3.
Impacto: 10.8. Cuartil: Q1
(1er decil)
Lage L., Rodriguez-Perez A.I., Villar-Cheda B., Labandeira-Garcia J.L., Dominguez-Meijide A.. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission. npj Parkinson's Disease. December 2024. DOI: 10.1038/s41531-024-00650-0.
Impacto: 6.7. Cuartil: Q1
(1er decil)
Rivas-Santisteban R., Muñoz A., Lillo J., Raïch I., Rodríguez-Pérez A.I., Navarro G., Labandeira-García J.L., Franco R.. Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons. npj Parkinson's Disease. December 2024. DOI: 10.1038/s41531-024-00827-7.
Impacto: 6.7. Cuartil: Q1
(1er decil)
Serrano-Marín J., Valenzuela R., Delgado C., Quijano A., Navarro G., Luis Labandeira –García J., Franco R.. Neuroprotective compounds alter the expression of genes coding for proteins related to mitochondrial function in activated microglia. Mitochondrion. September 2024. DOI: 10.1016/j.mito.2024.101934.
Impacto: 3.9. Cuartil: Q1
Borrajo M.L., Quijano A., Lapuhs P., Rodriguez-Perez A.I., Anthiya S., Labandeira-Garcia J.L., Valenzuela R., Alonso M.J.. Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity. Journal of Controlled Release. August 2024. DOI: 10.1016/j.jconrel.2024.06.051.
Impacto: 10.5. Cuartil: Q1
(1er decil)
Cruces-Sande A., Garrido-Gil P., Sierra-Paredes G., Vázquez-Agra N., Hermida-Ameijeiras Á., Pose-Reino A., Méndez-Álvarez E., Soto-Otero R.. Copper Overload Increased Rat Striatal Levels of Both Dopamine and Its Main Metabolite Homovanillic Acid in Extracellular Fluid. International Journal of Molecular Sciences. August 2024. DOI: 10.3390/ijms25158309.
Impacto: 4.9. Cuartil: Q1
García-Varela L., Codesido J., Perez-Pedrosa A., Muñoz-González M., Ramos-Docampo E., Rey-Bretal D., García-Otero X., Gómez-Lado N., Turrero A., Beiroa D., Isabel Rodríguez-Perez A., Vidal A., Fernández-Ferreiro A., Pubul V., Aguiar P.. Biodistribution and pharmacokinetics of [<sup>89</sup>Zr]-anti-VEGF mAbs using PET in glioblastoma rat models. International Journal of Pharmaceutics. 5 March 2024. DOI: 10.1016/j.ijpharm.2024.123795.
Impacto: 5.3. Cuartil: Q1
Moreno-Cascales M., Guerrero-Sánchez Y., Fernández-Villacañas M.A., Suarez-Quintanilla J.A., López-González L., González-Sequeros O.. Possible vascular complications due to anatomical variations in dental surgical treatments. European Journal of Anatomy. March 2024. DOI: 10.52083/xkvf1039.
Espinosa-Oliva A.M., Ruiz R., Soto M.S., Boza-Serrano A., Rodriguez-Perez A.I., Roca-Ceballos M.A., García-Revilla J., Santiago M., Serres S., Economopoulus V., Carvajal A.E., Vázquez-Carretero M.D., García-Miranda P., Klementieva O., Oliva-Martín M.J., Deierborg T., Rivas E., Sibson N.R., Labandeira-García J.L., Machado A., Peral M.J., Herrera A.J., Venero J.L., de Pablos R.M.. Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain. Neuropathology and Applied Neurobiology. February 2024. DOI: 10.1111/nan.12962.
Impacto: 4.0. Cuartil: Q1
Lage L., Rodríguez-Perez A.I., Labandeira-Garcia J.L., Dominguez-Meijide A.. Angiotensin type-1 receptor autoantibodies promote alpha-synuclein aggregation in dopaminergic neurons. Frontiers in Immunology. 2024. DOI: 10.3389/fimmu.2024.1457459.
Impacto: 5.7. Cuartil: Q1
Dragano N.R.V., Milbank E., Haddad-Tóvolli R., Garrido-Gil P., Nóvoa E., Fondevilla M.F., Capelli V., Zanesco A.M., Solon C., Morari J., Pires L., Estevez-Salguero Á., Beiroa D., González-García I., Barca-Mayo O., Diéguez C., Nogueiras R., Labandeira-García J.L., Rexen Ulven E., Ulven T., Claret M., Velloso L.A., López M.. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance. Molecular Metabolism. January 2024. DOI: 10.1016/j.molmet.2023.101840.
Impacto: 7.0. Cuartil: Q1
González-Vila A., Luengo-Mateos M., Silveira-Loureiro M., Garrido-Gil P., Ohinska N., González-Domínguez M., Labandeira-García J.L., García-Cáceres C., López M., Barca-Mayo O.. Astrocytic insulin receptor controls circadian behavior via dopamine signaling in a sexually dimorphic manner. Nature Communications. December 2023. DOI: 10.1038/s41467-023-44039-8.
Impacto: 14.7. Cuartil: Q1
(1er decil)
Chocarro J., Rico A.J., Ariznabarreta G., Roda E., Honrubia A., Collantes M., Peñuelas I., Vázquez A., Rodríguez-Pérez A.I., Labandeira-García J.L., Vila M., Lanciego J.L.. Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates. Brain. 1 December 2023. DOI: 10.1093/brain/awad331.
Impacto: 10.6. Cuartil: Q1
(1er decil)
Pedrosa M.A., Labandeira C.M., Lago-Baameiro N., Valenzuela R., Pardo M., Labandeira-Garcia J.L., Rodriguez-Perez A.I.. Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease. Antioxidants. December 2023. DOI: 10.3390/antiox12122045.
Impacto: 6.0. Cuartil: Q1
Rivas-Santisteban R., Rico A.J., Muñoz A., Rodríguez-Pérez A.I., Reyes-Resina I., Navarro G., Labandeira-García J.L., Lanciego J.L., Franco R.. Boolean analysis shows a high proportion of dopamine D<inf>2</inf> receptors interacting with adenosine A<inf>2A</inf> receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease. Neurobiology of Disease. November 2023. DOI: 10.1016/j.nbd.2023.106341.
Impacto: 5.1. Cuartil: Q1
Lopez-Lopez A., Valenzuela R., Rodriguez-Perez A.I., Guerra M.J., Labandeira-Garcia J.L., Muñoz A.. Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia. Antioxidants. July 2023. DOI: 10.3390/antiox12071454.
Impacto: 6.0. Cuartil: Q1
García-Caballero L., Gándara M., Cepeda-Emiliani A., Gallego R., Gude F., Suárez-Quintanilla J., Ramos-Barbosa I., Blanco-Carrión J.. Histological and histomorphometric study of human palatal mucosa: Implications for connective tissue graft harvesting. Journal of Clinical Periodontology. June 2023. DOI: 10.1111/jcpe.13800.
Impacto: 5.8. Cuartil: Q1
(1er decil)
Cepeda-Emiliani A., Gándara-Cortés M., Otero-Alén M., García H., Suárez-Quintanilla J., García-Caballero T., Gallego R., García-Caballero L.. Immunohistological study of the density and distribution of human penile neural tissue: gradient hypothesis. International Journal of Impotence Research. May 2023. DOI: 10.1038/s41443-022-00561-9.
Impacto: 2.8. Cuartil: Q2
Kulisevsky J., Martínez-Horta S., Campolongo A., Pascual-Sedano B., Marín-Lahoz J., Bejr-kasem H., Labandeira-Garcia J.L., Lanciego J.L., Puig-Davi A., Horta-Barba A., Pagonabarraga J., Rodríguez-Antigüedad J.. A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease. Parkinsonism and Related Disorders. May 2023. DOI: 10.1016/j.parkreldis.2023.105367.
Impacto: 3.1. Cuartil: Q2
Rivas-Santisteban R., Lillo J., Raïch I., Muñoz A., Lillo A., Rodríguez-Pérez A.I., Labandeira-García J.L., Navarro G., Franco R.. The cannabinoid CB<inf>1</inf> receptor interacts with the angiotensin AT<inf>2</inf> receptor. Overexpression of AT<inf>2</inf>-CB<inf>1</inf> receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned rats. Experimental Neurology. April 2023. DOI: 10.1016/j.expneurol.2023.114319.
Impacto: 4.6. Cuartil: Q1
Rodríguez-Pallares J., García-Garrote M., Parga J., Labandeira-García J.. Combined cell-based therapy strategies for the treatment of Parkinson's disease: Focus on mesenchymal stromal cells. Neural Regeneration Research. March 2023. DOI: 10.4103/1673-5374.350193.
Impacto: 5.9. Cuartil: Q1
Pedrosa M.A., Labandeira C.M., Valenzuela R., Quijano A., Sanchez-Andrade M., Suarez-Quintanilla J.A., Lanciego J.L., Labandeira-Garcia J.L., Rodriguez-Perez A.I.. AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability. Brain, Behavior, and Immunity. February 2023. DOI: 10.1016/j.bbi.2022.12.009.
Impacto: 8.8. Cuartil: Q1
(1er decil)
Milbank E., Dragano N., Vidal-Gómez X., Rivas-Limeres V., Garrido-Gil P., Wertheimer M., Recoquillon S., Pata M.P., Labandeira-Garcia J.L., Diéguez C., Nogueiras R., Martínez M.C., Andriantsitohaina R., López M.. Small extracellular vesicle targeting of hypothalamic AMPKα1 promotes weight loss in leptin receptor deficient mice. Metabolism: Clinical and Experimental. February 2023. DOI: 10.1016/j.metabol.2022.155350.
Impacto: 10.8. Cuartil: Q1
(1er decil)
Garrido-Gil P., Pedrosa M.A., Garcia-Garrote M., Pequeño-Valtierra A., Rodríguez-Castro J., García-Souto D., Rodríguez-Pérez A.I., Labandeira-Garcia J.L.. Microglial angiotensin type 2 receptors mediate sex-specific expression of inflammatory cytokines independently of circulating estrogen. GLIA. December 2022. DOI: 10.1002/glia.24255.
Impacto: 6.2. Cuartil: Q1
Labandeira C.M., Pedrosa M.A., Quijano A., Valenzuela R., Garrido-Gil P., Sanchez-Andrade M., Suarez-Quintanilla J.A., Rodriguez-Perez A.I., Labandeira-Garcia J.L.. Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease. npj Parkinson's Disease. December 2022. DOI: 10.1038/s41531-022-00340-9.
Rodríguez-Pena K., Salgado-Peralvo Á.O., Kewalramani N., Suárez-Quintanilla J.A., Suárez-Quintanilla J.M.. Selective serotonin reuptake inhibitors as a risk factor for dental implant failure: a retrospective clinical study. British Journal of Oral and Maxillofacial Surgery. December 2022. DOI: 10.1016/j.bjoms.2022.09.009.
Impacto: 1.8. Cuartil: Q3
Ni L., Liu L., Zhu W., Telljohann R., Zhang J., Monticone R.E., McGraw K.R., Liu C., Morrell C.H., Garrido-Gil P., Labandeira-Garcia J.L., Lakatta E.G., Wang M.. Inflammatory Role of Milk Fat Globule– Epidermal Growth Factor VIII in Age-Associated Arterial Remodeling. Journal of the American Heart Association. 6 September 2022. DOI: 10.1161/JAHA.121.022574.
Impacto: 5.4. Cuartil: Q2
Labandeira-Garcia J.L., Parga J.A.. Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene. Movement Disorders. August 2022. DOI: 10.1002/mds.29137.
Impacto: 8.6. Cuartil: Q1
(1er decil)
Labandeira C., Fraga-Bau A., Arias Ron D., Alvarez-Rodriguez E., Vicente-Alba P., Lago-Garma J., Rodriguez-Perez A.. Parkinson's disease and diabetes mellitus: Common mechanisms and treatment repurposing. Neural Regeneration Research. August 2022. DOI: 10.4103/1673-5374.332122.
Impacto: 6.1. Cuartil: Q1
González-García I., Freire-Agulleiro Ó., Nakaya N., Ortega F.J., Garrido-Gil P., Liñares-Pose L., Fernø J., Labandeira-Garcia J.L., Diéguez C., Sultana A., Tomarev S.I., Fernández-Real J.M., López M.. Olfactomedin 2 deficiency protects against diet-induced obesity. Metabolism: Clinical and Experimental. April 2022. DOI: 10.1016/j.metabol.2021.155122.
Impacto: 9.8. Cuartil: Q1
(1er decil)
Labandeira C.M., Pedrosa M.A., Suarez-Quintanilla J.A., Cortes-Ayaso M., Labandeira-García J.L., Rodríguez-Pérez A.I.. Angiotensin System Autoantibodies Correlate With Routine Prognostic Indicators for COVID-19 Severity. Frontiers in Medicine. 9 March 2022. DOI: 10.3389/fmed.2022.840662.
Impacto: 3.9. Cuartil: Q2
Quijano A., Diaz-Ruiz C., Lopez-Lopez A., Villar-Cheda B., Muñoz A., Rodriguez-Perez A.I., Labandeira-Garcia J.L.. Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures. Antioxidants. February 2022. DOI: 10.3390/antiox11020329.
Impacto: 7.0. Cuartil: Q1
(1er decil)
Rey-Martínez M.H., Ruiz-Sáenz P.L., Martínez-Rodríguez N., Barona-Dorado C., Meniz-García C., Brinkmann J.C.B., Suárez-Quintanilla J.A., Martínez-González J.M.. Analysis of the Radiological Changes of the Sinus Membrane Using Cone Beam Computed Tomography and Its Relationship with Dental Treatments. A Retrospective Study. Biology. February 2022. DOI: 10.3390/biology11020165.
Labandeira-Garcia J.L., Labandeira C.M., Valenzuela R., Pedrosa M.A., Quijano A., Rodriguez-Perez A.I.. Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment. Biomedicines. February 2022. DOI: 10.3390/biomedicines10020502.
Impacto: 4.7. Cuartil: Q1
Garcia-Garrote M., Parga J.A., Labandeira P.J., Labandeira-Garcia J.L., Rodriguez-Pallares J.. Dopamine regulates adult neurogenesis in the ventricular-subventricular zone via dopamine D3 angiotensin type 2 receptor interactions. Stem Cells. December 2021. DOI: 10.1002/stem.3457.
Impacto: 5.845. Cuartil: Q1
Parga J.A., Rodriguez-Perez A.I., Garcia-Garrote M., Rodriguez-Pallares J., Labandeira-Garcia J.L.. Nrf2 activation and downstream effects: Focus on parkinson’s disease and brain angiotensin. Antioxidants. November 2021. DOI: 10.3390/antiox10111649.
Impacto: 7.675. Cuartil: Q1
(1er decil)
Pérez-González A., Suárez-Quintanilla J.A., Otero-Rey E., Blanco-Carrión A., Gómez-García F.J., Gándara-Vila P., Martín-Biedma B., Pérez-Sayáns M.. Association between Xerostomia, oral and general health, and obesity in adults. A cross-sectional pilot study. Medicina Oral Patologia Oral y Cirugia Bucal. 1 November 2021. DOI: 10.4317/medoral.24731.
Impacto: 2.883. Cuartil: Q2
Santana-Mora U., López-Cedrún J., Suárez-Quintanilla J., Varela-Centelles P., Mora M.J., Da Silva J.L., Figueiredo-Costa F., Santana-Penín U.. Asymmetry of dental or joint anatomy or impaired chewing function contribute to chronic temporomandibular joint disorders. Annals of Anatomy. November 2021. DOI: 10.1016/j.aanat.2021.151793.
Impacto: 2.976. Cuartil: Q1
Rodriguez-Pallares J., Garcia-Garrote M., Parga J.A., Labandeira-Garcia J.L.. Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model. Journal of Cellular and Molecular Medicine. October 2021. DOI: 10.1111/jcmm.16900.
Impacto: 5.295. Cuartil: Q2
Martín-Montañez E., Valverde N., Ladrón de Guevara-Miranda D., Lara E., Romero-Zerbo Y.S., Millon C., Boraldi F., Ávila-Gámiz F., Pérez-Cano A.M., Garrido-Gil P., Labandeira-Garcia J.L., Santin L.J., Pavia J., Garcia-Fernandez M.. Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease. Redox Biology. October 2021. DOI: 10.1016/j.redox.2021.102095.
Impacto: 10.787. Cuartil: Q1
(1er decil)
Valenzuela R., Rodriguez-Perez A.I., Costa-Besada M.A., Rivas-Santisteban R., Garrido-Gil P., Lopez-Lopez A., Navarro G., Lanciego J.L., Franco R., Labandeira-Garcia J.L.. An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria. Redox Biology. October 2021. DOI: 10.1016/j.redox.2021.102078.
Impacto: 10.787. Cuartil: Q1
(1er decil)
Fernandez Ascariz L., Suarez Quintanilla J.A., Freire Dapena M.C., García-Caballero L., García Mato E., Limeres Posse J.. The diagonal earlobe crease: a histological and capillaroscopic analysis. European Journal of Dermatology. September 2021. DOI: 10.1684/ejd.2021.4123.
Impacto: 2.805. Cuartil: Q2
Garrido-Gil P., Rodriguez-Perez A.I., Lage L., Labandeira-Garcia J.L.. Estrogen deficiency and colonic function: Surgical menopause and sex differences in angiotensin and dopamine receptor interaction. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 1 September 2021. DOI: 10.1093/gerona/glaa244.
Impacto: 6.591. Cuartil: Q1
Lopez-Lopez A., Villar-Cheda B., Quijano A., Garrido-Gil P., Garcia-Garrote M., Díaz-Ruiz C., Muñoz A., Labandeira-Garcia J.L.. Nadph-oxidase, rho-kinase and autophagy mediate the (Pro)renin-induced pro-inflammatory microglial response and enhancement of dopaminergic neuron death. Antioxidants. September 2021. DOI: 10.3390/antiox10091340.
Impacto: 7.675. Cuartil: Q1
(1er decil)
Rodriguez-Perez A.I., Labandeira C.M., Pedrosa M.A., Valenzuela R., Suarez-Quintanilla J.A., Cortes-Ayaso M., Mayán-Conesa P., Labandeira-Garcia J.L.. Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19. Journal of Autoimmunity. August 2021. DOI: 10.1016/j.jaut.2021.102683.
Impacto: 14.511. Cuartil: Q1
(1er decil)
Labandeira C.M., Fraga-Bau A., Arias Ron D., Muñoz A., Alonso-Losada G., Koukoulis A., Romero-Lopez J., Rodriguez-Perez A.I.. Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists. Frontiers in Neuroendocrinology. July 2021. DOI: 10.1016/j.yfrne.2021.100914.
Impacto: 8.333. Cuartil: Q1
Pérez-Sayáns M., González-Juanatey J.R., Lorenzo-Pouso A.I., Chamorro-Petronacci C.M., Blanco-Carrión A., Marichalar-Mendía X., Somoza-Martín J.M., Suárez-Quintanilla J.A.. Metabolic syndrome and masticatory hypofunction: a cross-sectional study. Odontology. July 2021. DOI: 10.1007/s10266-020-00577-x.
Impacto: 2.885. Cuartil: Q2
Sucunza D., Rico A.J., Roda E., Collantes M., González-Aseguinolaza G., Rodríguez-Pérez A.I., Peñuelas I., Vázquez A., Labandeira-García J.L., Broccoli V., Lanciego J.. Glucocerebrosidase gene therapy induces alpha-synuclein clearance and neuroprotection of midbrain dopaminergic neurons in mice and macaques. International Journal of Molecular Sciences. 1 May 2021. DOI: 10.3390/ijms22094825.
Impacto: 6.208. Cuartil: Q1
Rivas-Santisteban R., Lillo J., Muñoz A., Rodríguez-Pérez A.I., Labandeira-García J.L., Navarro G., Franco R.. Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia. Neurotherapeutics. April 2021. DOI: 10.1007/s13311-020-00986-4.
Impacto: 6.088. Cuartil: Q1
Pérez-Sayáns M., Chamorro-Petronacci C.M., Baltazar F., Pires F.R., Ínsua Á., Suárez-Quintanilla J.A., Suárez-Peñaranda J.M.. Nestin expression is associated with relapses in head and neck lesions. Diagnostics. April 2021. DOI: 10.3390/diagnostics11040583.
Impacto: 3.992. Cuartil: Q2
Labandeira-Garcia J.L., Valenzuela R., Costa-Besada M.A., Villar-Cheda B., Rodriguez-Perez A.I.. The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons. Progress in Neurobiology. April 2021. DOI: 10.1016/j.pneurobio.2020.101919.
Impacto: 10.885. Cuartil: Q1
(1er decil)
Pedrosa M.A., Valenzuela R., Garrido-Gil P., Labandeira C.M., Navarro G., Franco R., Labandeira-Garcia J.L., Rodriguez-Perez A.I.. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19. Clinical Science. February 2021. DOI: 10.1042/CS20201511.
Impacto: 6.876. Cuartil: Q1
Villadiego J., Ramírez-Lorca R., Cala F., Labandeira-Garciá J.L., Esteban M., Toledo-Aral J.J., López-Barneo J.. Is Carotid Body Infection Responsible for Silent Hypoxemia in COVID-19 Patients?. Function. 2021. DOI: 10.1093/function/zqaa032.
Franco R., Lillo A., Rivas-Santisteban R., Rodríguez-Pérez A.I., Reyes-Resina I., Labandeira-García J.L., Navarro G.. Functional complexes of angiotensin-converting enzyme 2 and renin-angiotensin system receptors: Expression in adult but not fetal lung tissue. International Journal of Molecular Sciences. 2 December 2020. DOI: 10.3390/ijms21249602.
Impacto: 5.923. Cuartil: Q1
Lopez-Lopez A., Labandeira C.M., Labandeira-Garcia J.L., Muñoz A.. Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson's disease. British Journal of Pharmacology. December 2020. DOI: 10.1111/bph.15275.
Impacto: 8.739. Cuartil: Q1
(1er decil)
Suárez-Quintanilla J., Martín-Cruces J., Martín-Biedma B., Cobo J.L., Mérida-García A.J., de Vicente J.C., Junquera L.M., Mérida-Velasco J.R., Vega J.A.. The juxta-oral organ of Chievitz (organum yuxtaorale) updated: Embryology, anatomy, function and pathology. Annals of Anatomy. November 2020. DOI: 10.1016/j.aanat.2020.151582.
Impacto: 2.698. Cuartil: Q1
Franco R., Rivas-Santisteban R., Serrano-Marín J., Rodríguez-Pérez A.I., Labandeira-Garciá J.L., Navarro G.. SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production. Journal of Immunology. 1 September 2020. DOI: 10.4049/jimmunol.2000642.
Impacto: 5.422. Cuartil: Q2
González-Uriel P., Armesto Pérez V., Suárez-Quintanilla J.A.. Clinical anatomy of cervical spondylosis. European Journal of Anatomy. 1 September 2020. DOI: .
Rivas-Santisteban R., Rodriguez-Perez A.I., Muñoz A., Reyes-Resina I., Labandeira-García J.L., Navarro G., Franco R.. Angiotensin AT<inf>1</inf>and AT<inf>2</inf>receptor heteromer expression in the hemilesioned rat model of Parkinson's disease that increases with levodopa-induced dyskinesia. Journal of Neuroinflammation. 17 August 2020. DOI: 10.1186/s12974-020-01908-z.
Impacto: 8.322. Cuartil: Q1
(1er decil)
Chamorro-Petronacci C., Carreras-Presas C.M., Sanz-Marchena A., Rodríguez-Fernández M.A., Suárez-Quintanilla J.M., Rivas-Mundiña B., Suárez-Quintanilla J., Pérez-Sayáns M.. Assessment of the economic and health-care impact of covid-19 (Sars-cov-2) on public and private dental surgeries in spain: A pilot study. International Journal of Environmental Research and Public Health. 2 July 2020. DOI: 10.3390/ijerph17145139.
Impacto: 3.39. Cuartil: Q1
Rodriguez-Perez A.I., Garrido-Gil P., Pedrosa M.A., Garcia-Garrote M., Valenzuela R., Navarro G., Franco R., Labandeira-Garcia J.L.. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra. Brain, Behavior, and Immunity. July 2020. DOI: 10.1016/j.bbi.2019.12.011.
Impacto: 7.217. Cuartil: Q1
(1er decil)
Muñoz A., Lopez-Lopez A., Labandeira C.M., Labandeira-Garcia J.L.. Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA. Frontiers in Neuroanatomy. 4 June 2020. DOI: 10.3389/fnana.2020.00026.
Impacto: 3.856. Cuartil: Q1
(1er decil)
Sayáns M.P., Suárez Quintanilla J.A., Chamorro Petronacci C.M., Suárez Peñaranda J.M., Jornet P.L., García F.G., Sánchez Y.G.. Volumetric study of the maxillary sinus in patients with sinus pathology. PLoS ONE. June 2020. DOI: 10.1371/journal.pone.0234915.
Impacto: 3.24. Cuartil: Q2
Pérez-Sayáns M., Blanco-Carrión A., García-García A., Chamorro-Petronacci C.M., Ortega K.L., Suárez-Quintanilla J.. Alveolar bone loss, platelet and glycosylated haemoglobin levels in 239 patients. A clinical study. Medicina Oral Patologia Oral y Cirugia Bucal. May 2020. DOI: 10.4317/medoral.23175.
Impacto: 2.047. Cuartil: Q3
Diaz-Ruiz C., Villar-Cheda B., Dominguez-Meijide A., Garrido-Gil P., Guerra M.J., Labandeira-Garcia J.L.. Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and Neurodegeneration. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 14 February 2020. DOI: 10.1093/gerona/gly259.
Impacto: 6.053. Cuartil: Q1
(1er decil)
Scheggi S., Rossi F., Corsi S., Fanni S., Tronci E., Ludovica C., Vargiu R., Gambarana C., Muñoz A., Stancampiano R., Björklund A., Carta M.. BDNF Overexpression Increases Striatal D<inf>3</inf>Receptor Level at Striatal Neurons and Exacerbates D<inf>1</inf>-Receptor Agonist-Induced Dyskinesia. Journal of Parkinson's Disease. 2020. DOI: 10.3233/JPD-202061.
Impacto: 5.568. Cuartil: Q1
Labandeira-Garcia J.L., Garrido-Gil P., Pedrosa M.A., Labandeira C.M., Rodriguez-Perez A.I.. Interaction between brain angiotensin and dopaminergic systems and Parkinson’s disease. Genetics, Neurology, Behavior, and Diet in Parkinson’s Disease: The Neuroscience of Parkinson’s Disease, Volume 2. 1 January 2020. DOI: 10.1016/B978-0-12-815950-7.00029-1.
Sánchez-Guijo F., García-Olmo D., Prósper F., Martínez S., Zapata A., Fernández-Avilés F., Toledo-Aral J.J., Torres M., Fariñas I., Badimón L., Labandeira-García J.L., García-Sancho J., Moraleda J.M.. Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research. Cytotherapy. January 2020. DOI: 10.1016/j.jcyt.2019.11.001.
Impacto: 5.414. Cuartil: Q1
Seoane-Collazo P., Liñares-Pose L., Rial-Pensado E., Romero-Picó A., Moreno-Navarrete J.M., Martínez-Sánchez N., Garrido-Gil P., Iglesias-Rey R., Morgan D.A., Tomasini N., Malone S.A., Senra A., Folgueira C., Medina-Gomez G., Sobrino T., Labandeira-García J.L., Nogueiras R., Domingos A.I., Fernández-Real J.M., Rahmouni K., Diéguez C., López M.. Central nicotine induces browning through hypothalamic κ opioid receptor. Nature Communications. 1 December 2019. DOI: 10.1038/s41467-019-12004-z.
Impacto: 12.121. Cuartil: Q1
(1er decil)
Garcia-Garrote M., Perez-Villalba A., Garrido-Gil P., Belenguer G., Parga J.A., Perez-Sanchez F., Labandeira-Garcia J.L., Fariñas I., Rodriguez-Pallares J.. Interaction between angiotensin type 1, type 2, and mas receptors to regulate adult neurogenesis in the brain ventricular–subventricular zone. Cells. December 2019. DOI: 10.3390/cells8121551.
Impacto: 4.366. Cuartil: Q2
Folgueira C., Beiroa D., Porteiro B., Duquenne M., Puighermanal E., Fondevila M.F., Barja-Fernández S., Gallego R., Hernández-Bautista R., Castelao C., Senra A., Seoane-Collazo P., Gómez-Lado N., Aguiar P., Guallar D., Fidalgo M., Romero-Pico A., Adan R., Blouet C., Labandeira-García J.L., Jeanrenaud F., Kallo I., Liposits Z., Salvador J., Prevot V., Dieguez C., López M., Valjent E., Frühbeck G., Seoane L.M., Nogueiras R.. Hypothalamic dopamine signalling regulates brown fat thermogenesis. Nature Metabolism. 1 August 2019. DOI: 10.1038/s42255-019-0099-7.
Cruces-Sande A., Rodríguez-Pérez A.I., Herbello-Hermelo P., Bermejo-Barrera P., Méndez-Álvarez E., Labandeira-García J.L., Soto-Otero R.. Copper Increases Brain Oxidative Stress and Enhances the Ability of 6-Hydroxydopamine to Cause Dopaminergic Degeneration in a Rat Model of Parkinson’s Disease. Molecular Neurobiology. 1 April 2019. DOI: 10.1007/s12035-018-1274-7.
Impacto: 4.5. Cuartil: Q1
García-Piqueras J., Carcaba L., García-Mesa Y., Feito J., García B., Viña E., Suárez-Quintanilla J., Cobo J., Vega J.A., García-Suárez O.. Chondroitin Sulfate in Human Cutaneous Meissner and Pacinian Sensory Corpuscles. Anatomical Record. February 2019. DOI: 10.1002/ar.23951.
Impacto: 1.634. Cuartil: Q3
Parga J.A., Rodriguez-Perez A.I., Garcia-Garrote M., Rodriguez-Pallares J., Labandeira-Garcia J.L.. Data on the effect of Angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines. Data in Brief. December 2018. DOI: 10.1016/j.dib.2018.10.069.
Parga J.A., Rodriguez-Perez A.I., Garcia-Garrote M., Rodriguez-Pallares J., Labandeira-Garcia J.L.. Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells. Free Radical Biology and Medicine. December 2018. DOI: 10.1016/j.freeradbiomed.2018.10.409.
Impacto: 5.657. Cuartil: Q1
Muñoz A., Corrêa C.L., Lopez-Lopez A., Costa-Besada M.A., Diaz-Ruiz C., Labandeira-Garcia J.L.. Physical exercise improves aging-related changes in angiotensin, IGF-1, SIRT1, SIRT3, and VEGF in the substantia Nigra. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 10 November 2018. DOI: 10.1093/gerona/gly072.
Impacto: 4.711. Cuartil: Q1
(1er decil)
Hernández H.G., Sandoval-Hernández A.G., Garrido-Gil P., Labandeira-Garcia J.L., Zelaya M.V., Bayon G.F., Fernández A.F., Fraga M.F., Arboleda G., Arboleda H.. Alzheimer's disease DNA methylome of pyramidal layers in frontal cortex: Laser-assisted microdissection study. Epigenomics. November 2018. DOI: 10.2217/epi-2017-0160.
Impacto: 4.404. Cuartil: Q1
Rodriguez-Perez A.I., Sucunza D., Pedrosa M.A., Garrido-Gil P., Kulisevsky J., Lanciego J.L., Labandeira-Garcia J.L.. Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death. Neurotherapeutics. 14 October 2018. DOI: 10.1007/s13311-018-0646-z.
Impacto: 5.552. Cuartil: Q1
(1er decil)
Reyes-Resina I., Aguinaga D., Labandeira-García J.L., Lanciego J.L., Navarro G., Franco R.. Usefulness of identifying g-protein-coupled receptor dimers for diagnosis and therapy of neurodegenerative diseases and of gliomas. Histology and Histopathology. September 2018. DOI: 10.14670/HH-11-963.
Impacto: 1.777. Cuartil: Q3
Garrido-Gil P., Rodriguez-Perez A.I., Dominguez-Meijide A., Guerra M.J., Labandeira-Garcia J.L.. Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models. Molecular Neurobiology. 1 September 2018. DOI: 10.1007/s12035-018-0937-8.
Impacto: 4.586. Cuartil: Q1
Feito J., García-Suárez O., García-Piqueras J., García-Mesa Y., Pérez-Sánchez A., Suazo I., Cabo R., Suárez-Quintanilla J., Cobo J., Vega J.A.. The development of human digital Meissner's and Pacinian corpuscles. Annals of Anatomy. September 2018. DOI: 10.1016/j.aanat.2018.05.001.
Impacto: 2.241. Cuartil: Q2
Costa-Besada M.A., Valenzuela R., Garrido-Gil P., Villar-Cheda B., Parga J.A., Lanciego J.L., Labandeira-Garcia J.L.. Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans. Molecular Neurobiology. 1 July 2018. DOI: 10.1007/s12035-017-0805-y.
Impacto: 4.586. Cuartil: Q1
Cabanach R.G., Fernández-Cervantes R., Souto-Gestal A., Suárez-Quintanilla J.A.. Emotion regulation and stress in physiotherapy university students. Revista Mexicana de Psicologia. July 2018. DOI: .
Impacto: 0.321. Cuartil: Q4
Parga J.A., García-Garrote M., Martínez S., Raya Á., Labandeira-García J.L., Rodríguez-Pallares J.. Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons. Molecular Neurobiology. 1 June 2018. DOI: 10.1007/s12035-017-0681-5.
Impacto: 4.586. Cuartil: Q1
Lorenzo-Pouso A.I., Pérez-Sayáns M., Suárez-Quintanilla J.A., González-Palanca S.. Self-assessment of opinions, habits and oral health status by pregnant women in the south of Galicia, Spain. Semergen. 1 March 2018. DOI: 10.1016/j.semerg.2017.04.002.
Pignataro D., Sucunza D., Rico A.J., Dopeso-Reyes I.G., Roda E., Rodríguez-Perez A.I., Labandeira-Garcia J.L., Broccoli V., Kato S., Kobayashi K., Lanciego J.L.. Gene therapy approaches in the non-human primate model of Parkinson’s disease. Journal of Neural Transmission. 1 March 2018. DOI: 10.1007/s00702-017-1681-3.
Impacto: 2.903. Cuartil: Q2
Garrido-Gil P., Dominguez-Meijide A., Moratalla R., Guerra M.J., Labandeira-Garcia J.L.. Aging-related dysregulation in enteric dopamine and angiotensin system interactions: Implications for gastrointestinal dysfunction in the elderly. Oncotarget. 2018. DOI: 10.18632/oncotarget.24330.
Navarro G., Borroto-Escuela D., Angelats E., Etayo Í., Reyes-Resina I., Pulido-Salgado M., Rodríguez-Pérez A.I., Canela E.I., Saura J., Lanciego J.L., Labandeira-García J.L., Saura C.A., Fuxe K., Franco R.. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB<inf>1</inf> and CB<inf>2</inf> receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia. Brain, Behavior, and Immunity. January 2018. DOI: 10.1016/j.bbi.2017.08.015.
Impacto: 6.17. Cuartil: Q1
(1er decil)
Dopeso-Reyes I.G., Sucunza D., Rico A.J., Pignataro D., Marín-Ramos D., Roda E., Rodríguez-Pérez A.I., Labandeira-García J.L., Lanciego J.L.. Glucocerebrosidase expression patterns in the non-human primate brain. Brain Structure and Function. 1 January 2018. DOI: 10.1007/s00429-017-1504-1.
Impacto: 3.622. Cuartil: Q1
(1er decil)
Labandeira-Garcia J.L., Costa-Besada M.A., Labandeira C.M., Villar-Cheda B., Rodríguez-Perez A.I.. Insulin-like growth factor-1 and neuroinflammation. Frontiers in Aging Neuroscience. 3 November 2017. DOI: 10.3389/fnagi.2017.00365.
Impacto: 3.582. Cuartil: Q2
Tronci E., Napolitano F., Muñoz A., Fidalgo C., Rossi F., Björklund A., Usiello A., Carta M.. BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Experimental Neurology. November 2017. DOI: 10.1016/j.expneurol.2017.07.017.
Impacto: 4.483. Cuartil: Q1
Garrido-Gil P., Fernandez-Rodríguez P., Rodríguez-Pallares J., Labandeira-Garcia J.L.. Laser capture microdissection protocol for gene expression analysis in the brain. Histochemistry and Cell Biology. 1 September 2017. DOI: 10.1007/s00418-017-1585-1.
Impacto: 2.164. Cuartil: Q1
Garrido-Gil P., Rodriguez-Perez A.I., Fernandez-Rodriguez P., Lanciego J.L., Labandeira-Garcia J.L.. Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells. Brain Structure and Function. 1 August 2017. DOI: 10.1007/s00429-016-1357-z.
Impacto: 4.231. Cuartil: Q1
(1er decil)
Muinelo-Lorenzo J., Fernández-Alonso A., Smyth-Chamosa E., Suárez-Quintanilla J.A., Varela-Mallou J., Suárez-Cunqueiro M.M.. Predictive factors of the dimensions and location of mental foramen using cone beam computed tomography. PLoS ONE. August 2017. DOI: 10.1371/journal.pone.0179704.
Impacto: 2.766. Cuartil: Q1
Rapado-González O., Suárez-Quintanilla J., Suárez-Cunqueiro M.. Anatomical variations of the greater palatine canal in cone-beam computed tomography. Surgical and Radiologic Anatomy. 1 July 2017. DOI: 10.1007/s00276-016-1791-x.
Impacto: 1.003. Cuartil: Q4
Labandeira-Garcia J.L., Rodríguez-Perez A.I., Garrido-Gil P., Rodriguez-Pallares J., Lanciego J.L., Guerra M.J.. Brain renin-angiotensin system and microglial polarization: Implications for aging and neurodegeneration. Frontiers in Aging Neuroscience. 3 May 2017. DOI: 10.3389/fnagi.2017.00129.
Impacto: 3.582. Cuartil: Q2
Dominguez-Meijide A., Rodriguez-Perez A.I., Diaz-Ruiz C., Guerra M.J., Labandeira-Garcia J.L.. Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures. Brain, Behavior, and Immunity. 1 May 2017. DOI: 10.1016/j.bbi.2017.02.013.
Impacto: 6.306. Cuartil: Q1
(1er decil)
Rico A.J., Dopeso-Reyes I.G., Martínez-Pinilla E., Sucunza D., Pignataro D., Roda E., Marín-Ramos D., Labandeira-García J.L., George S.R., Franco R., Lanciego J.L.. Neurochemical evidence supporting dopamine D1–D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation. Brain Structure and Function. 1 May 2017. DOI: 10.1007/s00429-016-1306-x.
Impacto: 4.231. Cuartil: Q1
(1er decil)